In what is being described as the world's longest-distance robot-assisted cardiac telesurgery ever performed, an India-developed surgical robotic platform has been used to complete a coronary bypass procedure across roughly 20,000 kilometres of fibre-optic network. The surgeon operated remotely from Georgetown, Guyana on a patient at IRCAD India in Indore, with the procedure taking around four hours and fifty minutes and a measured communication latency of 290 to 300 milliseconds.

The procedure was carried out by Dr Sudhir Srivastava, a cardiac surgeon and founder of SS Innovations International — the Nasdaq-listed company behind the SSi Mantra surgical robotic system. The achievement was announced on 4 June 2026 by SS Innovations, having actually been completed on 26 May 2026, the day of Guyana's 60th Independence anniversary.

The procedure

The operation involved a Left Internal Mammary Artery (LIMA) takedown — a key step in coronary artery bypass grafting, where a section of the artery running along the inside of the chest wall is freed up so it can be re-routed to supply blood to a blocked region of the heart. The procedure is one of the more technically demanding steps in cardiac surgery, requiring fine-grained control of robotic instruments inside a confined surgical field.

For the operation, Dr Srivastava worked from a surgical console at the Georgetown Public Hospital Corporation in Guyana, while the patient-side robotic system, an on-site clinical team and supporting infrastructure were in Indore, at IRCAD India — the surgical training and research institute that has been a recurring partner in long-distance telesurgery trials. The two ends were connected by a dedicated fibre-optic link.

The technology behind it

The SSi Mantra is an Indian-developed surgical robotic platform built by SS Innovations International. Its tele-surgical architecture has been engineered specifically to maintain procedural precision over long-haul, high-latency network environments — the central technical challenge in long-distance robotic surgery. Even a few hundred milliseconds of delay between a surgeon's hand movement and the responding motion of the robotic instrument can, if not properly managed, compromise procedural safety.

The 290-300 millisecond latency observed during this procedure is at the higher end of what telesurgical systems have historically operated at. The fact that a long, technically intricate cardiac operation could be conducted at that latency without complications is one of the headline data points from the procedure.

The system has now logged 173 telesurgeries globally and remains, by the company's account, the only surgical robotic platform that has been used for cardiac telesurgery — 22 of them performed using SSi Mantra to date.

Breaking their own previous record

The 20,000-kilometre procedure breaks a record that was itself set by the same surgeon-system combination less than a year earlier. In July 2025, Dr Srivastava had performed what was then described as the world's first intercontinental robotic cardiac telesurgery, operating from IRCAD in Strasbourg, France on a patient in Indore — a network distance of roughly 10,000 kilometres.

The new procedure has roughly doubled that distance. The progression in less than twelve months — from a first intercontinental procedure to a record-breaking transatlantic-plus-trans-hemisphere one — suggests a steeper-than-expected learning curve for the platform's tele-surgical architecture.

The Guyana side of the story

For Guyana, the procedure has carried symbolism beyond its medical significance. The country has launched a National Robotic Surgery Programme alongside the announcement, and is positioning itself as a regional hub for robotic surgery training within the Caribbean. The robotic system installed in Georgetown has been renamed "Mantra Freedom 60" in honour of Guyana's Diamond Jubilee Independence anniversary on 26 May.

According to the Guyanese government, three robotic procedures were conducted on the inaugural day of the programme. President Mohamed Irfaan Ali has publicly framed the development as evidence of Guyana's emergence as an "emerging regional hub for advanced robotic healthcare". Guyanese medical teams have already been sent to India for specialised training, and the SSi Mantra ecosystem is being woven into Guyana's longer-term plan to extend robotic surgery training to other Caribbean healthcare professionals.

Why this matters — for India

For India, three threads converge in this story. The first is medical-technology export competence: SS Innovations is an Indian-founded surgical robotics company, the SSi Mantra system is Indian-made, and the system is now operating in 14 countries with regulatory approval. That places it in the very small global cohort of mature surgical robotic platforms — a field that has long been dominated by US-based players.

The second is the role of IRCAD India in Indore. The institute has emerged as the recurring patient-side location for SSi Mantra's most distant procedures — first Strasbourg in 2025, now Georgetown in 2026 — quietly establishing itself as one of the world's leading telesurgery destinations.

The third is the broader vision around medical access. The idea that a cardiac surgeon in one continent can operate, in real time, on a patient on another continent fundamentally changes the calculus of access to specialised surgical expertise. For patients in countries with limited cardiac surgery capacity, a working telesurgery network could compress the geography of healthcare in ways that purely physical surgeon-presence cannot.

The road ahead

Telesurgery at this scale and complexity is still at an early stage. The technology, infrastructure and regulatory frameworks needed to make such procedures routine — rather than landmark events — are not yet in place anywhere in the world. A reliable, low-latency fibre-optic link is required between the surgical console and patient-side robot. Cross-border regulatory approval is needed. So is a clinically credentialed, on-site team that can take over instantly if anything goes wrong.

The cumulative SSi Mantra count of 173 telesurgeries — including 22 cardiac — is, in that context, an important data set. It is small enough that each procedure remains significant, but large enough that broader patterns about safety, latency tolerance and clinical outcomes can begin to be studied.

For India, the procedure adds one more milestone to a sector — homegrown surgical robotics — that has, until recently, sat outside the country's main story about its technology economy. Whether the SSi Mantra platform and India's emerging tele-surgery ecosystem can scale from headline procedures into routine clinical infrastructure will be the next chapter to watch.